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RESEARCH ARTICLE
Bacillus pumilus probiotic feed 
supplementation mitigates Lawsonia 
intracellularis shedding and lesions
Tanja Opriessnig1,2* , Anbu K. Karuppannan2, Dana Beckler3, Tahar Ait‑Ali1, Ana Cubas‑Atienzar1 
and Patrick G. Halbur2
Abstract 
The causative agent of ileitis, Lawsonia intracellularis, is commonly associated with diarrhea and reduced weight gain 
in growing pigs. The effect of in‑feed probiotics on L. intracellularis infection dynamics was evaluated. In brief, 70 
2.5‑week‑old‑pigs were randomly divided into six groups with 10–20 pigs each. All pigs were fed an age appropri‑
ate base ration for the duration of the study, which was supplemented with one of three Bacillus strains including B. 
amyloliquefaciens (T01), B. licheniformis (T02) and B. pumilus (T03). Another group was orally vaccinated with a com‑
mercial live L. intracellularis vaccine (VAC) at 3 weeks of age. At 7 weeks of age, T01‑LAW, T02‑LAW, T03‑LAW, VAC‑LAW 
and the POS‑CONTROL groups were challenged with L. intracellularis while the NEG‑CONTROL pigs were not chal‑
lenged. All pigs were necropsied 16 days later. By the time of inoculation, all VAC‑LAW pigs had seroconverted and at 
necropsy 10–65% of the pigs in all other challenged groups were also seropositive. The results indicate a successful 
L. intracellularis challenge with highest bacterial DNA levels in POS‑CONTROL pigs, VAC‑LAW pigs and T01‑LAW pigs. 
There was a delay in onset of shedding in T02‑LAW and T03‑LAW groups, which was reflected in less severe macro‑
scopic and microscopic lesions, reduced intralesional L. intracellularis antigen levels and a lower area under the curve 
for bacterial shedding. Under the study conditions, two of the probiotics tested suppressed L. intracellularis infection. 
The obtained findings show the potential of probiotics in achieving antibiotic‑free control of L. intracellularis.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Lawsonia intracellularis, an obligate intracellular bac-
terium [1, 2], is the causative agent of ileitis in pigs [3] 
and infection of pig herds with L. intracellularis infec-
tion is commonly associated with economic losses [4]. 
Clinical signs may include diarrhea, reduced weight gain, 
decreased feed efficiency, and increased (highly variable) 
mortality rates [5–7]. L. intracellularis infections often 
are exacerbated by co-infecting pathogens [7, 8]. The dis-
ease course can be acute or chronic [7]. It is well recog-
nized that pigs can also be infected subclinically [9, 10].
Lawsonia intracellularis is transmitted among pigs by 
the oral-fecal route. The organism has been shown to 
survive in the environment for up to 2  weeks in a tem-
perature range of 5–15  °C [11]. It has been established 
that  104–106 organisms are sufficient to infect a pig [5, 
10]. Infected pigs, including those subclinically-infected, 
actively shed the organism for 12  weeks or longer [11]. 
Transmission between herds may occur via contaminated 
equipment, insects or rodents [7, 12].
Control of L. intracellularis infection is mainly accom-
plished by treatment with antibiotics such as tiamulin, 
tylosin, chlortetracycline, lincomycin and olaquindox 
[6, 13], which are typically administered as standard 
doses approved by regulatory agencies in each country. 
These antibiotics are also used prophylactically and have 
been shown to reduce clinical signs, histological lesions 
and fecal shedding of the organism. An oral live vac-
cine and an inactivated parenteral vaccine are licensed 
for use in commercial pig production and are known to 
elicit humoral and cell mediated immunity [11, 14–17]. 
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Vaccination does not completely prevent L. intracellula-
ris shedding and is therefore occasionally used in combi-
nation with antibiotics [18]. In addition, an antibiotic-free 
feeding window is required for successful administration 
of live vaccine. However, with the increase in voluntary 
and mandatory antibiotic free pig husbandry practices, 
the control of L. intracellularis infection poses challenges 
for producers and veterinarians.
Probiotic bacteria are widely used in human nutrition. 
Major proposed probiotic mechanisms include competi-
tive exclusion of pathogenic microorganisms, enhance-
ment of the epithelial barrier, modulation of the immune 
system and others. Usage of probiotics is considered by 
many as an alternative to prophylactic antibiotic in-feed 
supplementation [19]. Several species of bacteria, such as 
Bacillus spp., are considered to have probiotic potential 
[20]. The objective of this study was to compare the effect 
of Bacillus amyloliquefaciens, Bacillus licheniformis and 
Bacillus pumilus on L. intracellularis infection. The 
results were directly compared to those obtained with a 
commercial live L. intracellularis vaccine.
Materials and methods
Animals and housing
Seventy 2.5-week-old age crossbred pigs were purchased 
from a L. intracellularis-free source herd where the 
dams were regularly tested and found to be negative for 
L. intracellularis antibodies using a commercial ELISA 
 (SVANOVIR® L. intracellularis/Ileitis-Ab, Svanova, Upp-
sala, Sweden). The pigs were transported to the Livestock 
Infectious Disease Isolation Facility at Iowa State Univer-
sity and randomly allocated into six experimental groups 
housed in four separate BSL-2 rooms with 1–3 pens 
(approximately 10  m2 each) of 10 pigs each equipped 
with a nipple waterer and a self-feeder (Figure  1). Spe-
cifically, the T01-LAW, T02-LAW and T03-LAW were 
housed in a single room with three separate pens approx-
imately 2 m apart from each other (Figure 1).
Experimental design and sample collection
At arrival, the pigs were randomly assigned to six treat-
ment groups with 10–20 pigs each (Figure 2). At 3 weeks 
of age, the pigs were either vaccinated with a commer-
cial oral vaccine against L. intracellularis (VAC-LAW), 
were supplied feed supplemented with one of the three 
probiotics (T01-LAW, B. amyloliquefaciens; T02-LAW, B. 
licheniformis; T03-LAW, B. pumilus), or remained non-
treated (NEG-CONTROL, POS-CONTROL). At 7 weeks 
of age all groups except the NEG-CONTROL group were 
challenged with gut homogenate containing L. intracel-
lularis by gastric gavage. Blood samples were collected 
from all pigs on a weekly basis. Rectal swabs (in 1  mL 
saline) were collected at arrival of the pigs at the research 
facility, prior to inoculation and at day post-inoculation 
(dpi) 2, 4, 6, 8, 10, 12 and 15.
Feed
The feed used in this study was produced by a local feed 
mill (Heartland Co-Op, Prairie city, IA, USA) without 
addition of antibiotics or animal proteins. Two different 
Figure 1 Room and pen layout for the study. Dashed or solid arrows indicate the flow direction of animal caretakers and research personnel in 
each treatment room to avoid room‑to‑room contamination.
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regular base diets, HLN2 and HLN3, were fed to the pigs 
from 2.5 to 6  weeks (HLN2) and 6 to 9  weeks (HLN3; 
Table 1). A portion of the base diet was supplemented in 
the feed mill with 1 × 1012 colony forming units (CFU) 
per metric ton of Bacillus amyloliquefaciens (T01; 40.9 g/
ton), Bacillus licheniformis (T02; 16.7 g/ton) or Bacillus 
pumilus (T03; 23.7 g/ton). Each different feed batch was 
color coded, labeled with Base, T01, T02 or T03, trans-
ported to the Iowa State University research facility and 
stored at 22  °C in a dark, dry storage room. The room 
temperature in the storage room was monitored daily. 
The pigs were fed ad libidum for the duration of the 
study with their allocated feed (Base, T01, T02 or T03) as 
outlined in Figure 2.
Vaccination
Pigs in the VAC-LAW group were vaccinated with a 
commercial L. intracellularis vaccine  (Enterisol® Ile-
itis, Boehringer Ingelheim, serial number 3040187B) at 
3 weeks of age. This particular vaccine is a one dose prod-
uct, contains a live bacterial culture, and is given orally. 
Prior to vaccination the vaccine was freshly reconstituted 
according to the manufacturer’s instructions and admin-
istered to each VAC-LAW pig by slowly dripping 2 mL of 
the vaccine with a syringe into the mouth.
Inoculation
Inoculation was done when the pigs were 7  weeks old, 
28  days post L. intracellularis vaccination, using an 
intestinal homogenate from an experimentally infected 
pig containing approximately 3 × 107 L. intracellularis 
organisms per mL. The L. intracellularis inoculum was 
obtained from a commercial supplier (Gutbugs Inc, Fer-
gus Falls, MN, USA). The L. intracellularis concentration 
in the inoculum was determined by quantitative PCR 
[21, 22]. The inoculum was tested previously and found 
Figure 2 Experimental design including time lines and major sampling events. Base, base diet; T01, base diet with Bacillus amyloliquefaciens, 
TO2, base diet with Bacillus licheniformis, and T03, base diet with Bacillus pumilus. 
Table 1 Base feed composition of the growth phase diets 
used 
Ingredient HLN2
2.5–6 weeks of age
HLN3
6–9 weeks 
of age
Moisture % 10.5 11.3
Fat % 5.5 5.5
Crude fiber % 2.6 2.7
Calcium % 0.72 0.6
Phosphorus % 0.65 0.56
Salt % 0.7 0.55
Copper, added ppm 144 188
Iodine, added ppm 0.62 0.39
Iron, added ppm 119 132
Manganese, added ppm 38 32
Selenium, added ppm 0.26 0.24
Zinc, added ppm 2505 1572
Metabolicenergy, kcal/lb 1540 1557
Crude protein % 20.6 20.0
Lysine % 1.52 1.41
Digestible lysine % 1.37 1.27
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to be negative for presence of different enteropathogens 
such as Salmonella enterica, enterotoxigenic Escherichia 
coli, oocysts or parasite eggs. In brief, the inoculum was 
thawed shortly prior to the inoculation and was trans-
ported/stored in several independent smaller contain-
ers on ice. Each pig was briefly restrained with a snare 
and 35 mL of the homogenate was administered by gas-
tric gavage. The overall inoculation took approximately 
45  min for all pigs. The order of inoculation was T03-
LAW group first followed by T02-LAW, T01-LAW, POS-
CONTROL pigs and finally the VAC-LAW pigs.
Clinical assessment
The pigs were weighed at arrival (2.5  weeks of age), 
at inoculation (7  weeks of age, dpi 0) and at necropsy 
(9 weeks of age, dpi 16; Figure 2). In addition, fecal con-
sistency was assessed on dpi 0, 2, 4, 6, 8, 10, 12 and 15. 
Specifically, the scores included 0 (normal, formed feces), 
1 (semisolid feces), 2 (pasty feces), and 3 (watery/liquid 
feces).
Necropsy
The pigs were euthanized by barbiturate overdose and 
presence and degree of macroscopic lesions were exam-
ined and scored by a veterinary pathologist (PGH) 
blinded to treatment group status. Specifically, ileum 
mucosal thinking was subjectively assessed using a score 
ranging from 0 (normal), 1 (mild), 2 (moderate), and 3 
(severe). If present, the length of a given lesion was not 
assessed. However, to assess distribution by histopathol-
ogy three sections of ileum (3–5 cm apart) and three sec-
tions of colon (3–5  cm apart) were collected from each 
pig. Samples from the ileum, colon and mesenteric lymph 
node were collected and as per standard research proto-
cols frozen at −80  °C or fixed in 10% buffered formalin 
for histological analysis.
Laboratory analyses
Serology
The L. intracellularis-specific antibody response was 
determined using the  SVANOVIR® L. intracellularis/
Ileitis-Ab antibody test (Svanova, Uppsala, Sweden), a 
competitive ELISA, as per the manufacturer’s instruc-
tions. A 40% inhibition of the supplied standard positive 
serum was set as the criteria for a valid assay. A sample 
with more than 30% inhibition was considered positive, 
and a sample with less than 30% inhibition was consid-
ered negative.
DNA extraction
Lawsonia intracellularis DNA was extracted from 
the fecal swabs using the KingFisher  Flex® magnetic 
bead-based nucleic acid extraction platform and the 
MagMAX-96 nucleic acid isolation kit (ThermoFisher, 
Waltham, MA, USA).
Quantitative real‑time PCR
A standard curve with a known amount of L. intracellula-
ris was generated to establish the conditions for bacteria 
quantification initially. The copy numbers of L. intracel-
lularis in the rectal swabs were estimated using a quan-
titative real-time PCR assay with the following primers 
and probe: forward primer, 5′-GCG CGC GTA GGT GGT 
TAT AT-3′); reverse primer, 5′-GCC ACC CTC TCC GAT 
ACT CA-3′; probe, 5′-FAM-CAC CGC TTA ACG GTG 
GAA CAG CCT T-TAMRA-3′ [22]. The assay was per-
formed in a ABI7500 Fast PCR machine with TaqMan 
Universal real-time PCR Master Mix (ThermoFisher, 
Waltham, MA, USA) using the following cycling condi-
tions: initial incubation 50  °C for 2  min, incubation at 
95 °C for 10 min, which was following by 40 cycling steps 
with 15 s at 95 °C and 1 min at 60 °C. A cycle threshold of 
38 or greater was considered negative. Appropriate nega-
tive and positive controls were included in each extrac-
tion and real-time PCR run.
Histopathology
Microscopic lesions were assessed by a veterinary pathol-
ogist (TO) blinded to the treatment status. Intestinal sec-
tions including several sections of ileum and colon were 
scored for the presence of crypt epithelial hyperplasia 
characteristic of L. intracellularis infection (0, normal; 1, 
mild; 2, moderate; 3, marked with or without crypt her-
niation into the submucosa). While inflammation is not 
a prominent feature with L. intracellularis infection, the 
sections were also scored for presence of inflammation 
(0, normal; 1, mild cellular infiltrate; 2, moderate cellular 
infiltrate with or without submucosal infiltrate; 3, marked 
cellular infiltrate with or without submucosal infiltrate).
L. intracellularis immunohistochemistry
Lawsonia intracellularis antigen-specific IHC was per-
formed on the intestinal sections as described [23]. 
The presence and amount of L. intracellularis antigen 
was scored and ranged from 0 (no signal), 1 (few focal 
crypts showing low numbers of enterocyte staining), 2 
(few multifocal crypts showing low-moderate amounts 
of enterocytes with staining), to 3 (most crypts in most 
sections showing marked apical enterocyte labelling). 
To simplify the analysis, a combined ileum lesion score 
was introduced for which the scores for crypt enterocyte 
hyperplasia, inflammation and amount of L. intracellu-
laris antigen were combined for a maximum score of 9. 
Using this combined ileum lesion score, the lesions were 
classified as absent (score of 0), mild (scores of 1, 2 or 3), 
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moderate (scores of 4, 5 and 6) and severe (scores of 7, 8 
and 9).
Periodic acid Schiff staining
For the Periodic acid Schiff (PAS) staining, fixed paraf-
fin-embedded ileum sections from pigs were dewaxed 
and rehydrated according to standard protocols. Follow-
ing this, sections were immersed in 1% periodic acid for 
5 min and in Schiff’s reagent for 15 min as described [24]. 
Slides were then immersed in warm water to intensify 
the red staining of the goblet cells. The slides were coun-
terstained with Haemalum Mayer (Sigma-Aldrich Com-
pany Ltd, Dorset, UK) for 5  min and dipped for 2  min 
with Scots tap water. The tissue sections were washed in 
running tap water and mounted with mounting medium 
(Fisher Scientific, Loughborough, UK).
Intestinal alkaline phosphatase staining
Intestinal alkaline phosphatase (IAP) was stained with 
 Vector® Red Alkaline Phosphatase Substrate (Vector 
Laboratories, Cambridge, UK) according to manufac-
turer instructions. Slides were counterstained with Hae-
malum Mayer and mounted as described for the PAS 
staining.
Quantitative image analysis
For quantitative analysis of PAS and IAP stained slides 
were scanned using NanoZoomer XR digital slide scan-
ner (Hamamatsu Photonics, Hamamatsu, Japan). For 
PAS staining, images were captured using brightfield, 
and for IAP a combination of brightfield and Texas red 
filter was used. Digital images were acquired at 40× mag-
nification and analyzed using open-access image analy-
sis software ImageJ version 1.49 (National Institutes of 
Health, Bethesda, MD, USA). Staining was analyzed by 
quantifying the intensity of the entire sections and a total 
of three sections per staining were quantified. Briefly, the 
spectrally opposite color channel was selected, and the 
intensity threshold was adjusted to highlight goblet cells 
for PAS staining or the villi for IAP staining [16].
Statistical analysis
The statistical analysis was performed using JMP software 
(JMP version Pro 13.1.0, SAS Institute Inc., Cary, NC, 
USA). Summary statistics were calculated to assess the 
overall quality of the data. Analysis of variance (ANOVA) 
was used for cross-sectional assessment of the average 
daily weight gain (ADG) and level of fecal shedding of L. 
intracellularis. Real-time PCR results (copies per fecal 
swab) were  log10 transformed, demonstrated a normal 
distribution, and were then analyzed. The significance 
level was P < 0.05 followed by pairwise testing using the 
Tukey–Kramer adjustments to identify the groups that 
were different. Non-repeated measures of necropsy and 
histopathology data were assessed using non-parametric 
Kruskal–Wallis ANOVA. If a non-parametric ANOVA 
test was significant (P < 0.05), then Wilcoxon tests were 
used to assess the differences of pairs of groups. Differ-
ences in incidence were evaluated by using Fisher’s exact 
test. The area under the curve (AUC) of bacterial shed-
ding of each animal and the total AUC for each group 
was calculated using the log transformed values of the 
bacterial loads over time. One-way ANOVA and a Bon-
ferroni post hoc test were used to compare groups.
To determine a cutoff for L. intracellularis values of 
infected (T01-LAW, T02-LAW, T03-LAW, VAC-LAW 
and POS-CONTROL pigs) and non-infected pigs (NEG-
CONTROL) based on PAS and IAP staining intensity in 
ileum sections, receiver operating characteristic (ROC) 
curve analysis SPSS statistics (Version 23.0. IBM Corp. 
Armonk, NY, USA) was used. The cutoff was calculated 
using the Youden Index. Correlations of PAS or IAP val-
ues with overall ileum lesion severity or L. intracellularis 
DNA shedding length in fecal swabs were also calculated 
and compared as described [25]. Specifically, DNA shed-
ding length was done by counting consecutive L. intracel-
lularis PCR positive rectal swabs over time in a given pig.
Results
L. intracellularis‑specific antibody responses
At arrival in the research facility, all pigs were negative 
for L. intracellularis antibodies (data not shown). At the 
day of inoculation (28  days post-vaccination) all VAC-
LAW pigs had seroconverted with a group mean per-
centage of inhibition value ± SEM of 53.1 ± 1.9 which 
was significantly (P < 0.05) higher compared to all other 
groups indicating successful vaccination of this group. 
The number of pigs that seroconverted within the 15 days 
between L. intracellularis inoculation and blood col-
lection prior to necropsy was 4/10 in the T01-LAW 
group (group mean/SEM; 30.1 ± 6.9), 1/10 in the T02-
LAW group (14.7 ± 2.4), 1/10 in the T03-LAW group 
(12.8 ± 4.2), 10/10 in the VAC-LAW group (44.5 ± 1.8), 
0/10 in the NEG-CONTROL group (7.2 ± 1.6) and 13/20 
in the POS-CONTROL group (33.9 ± 4.4).
Clinical signs and average daily gain
There were no clinical signs in any of the pigs pre-
sent prior to L. intracellularis inoculation. Pigs in the 
NEG-CONTROL group remained free of clinical signs 
throughout the study period. Individual pigs in all L. 
intracellularis groups had semisolid or pasty feces on 
single days throughout the study. Watery or bloody diar-
rhea (score 3) was present in 4/20 POS-CONTROL pigs 
and 1/10 VAC-LAW pigs by dpi 15. The average daily 
gain (ADG) before and after challenge is summarized 
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in Table  2. After L. intracellularis infection, all infected 
groups had significantly less ADG compared to the NEG-
CONTROL group without significant differences among 
L. intracellularis infected groups.
L. intracellular shedding
Lawsonia intracellularis DNA was never detected in 
rectal swabs of any of the NEG-CONTROL pigs for 
the duration of the study. L. intracellularis DNA was 
also not detected in any of the other groups at arrival 
at the research facility or on the day of inoculation. L. 
intracellularis shedding was first detected in a POS-
CONTROL pig by dpi 2. The prevalence rates of L. 
intracellularis shedding in fecal swabs are summarized 
in Figure 3. There was a delay in shedding in the T02-
LAW and T03-LAW groups compared to the POS-
CONTROL and VAC-LAW groups with PCR positive 
pigs first detected at dpi 6 (2/10; T02-LAW) or dpi 8 
(2/10; T03-LAW) (Figure  4). The prevalence of PCR 
positive pigs was significantly lower in T02-LAW and 
T03-LAW pigs compared to POS-CONTROL and 
VAC-LAW pigs on dpi 6 and 8. A summary of the 
group mean log genomic numbers of L. intracellularis 
for each dpi and the shedding length in weeks is pre-
sented in Table 3. For the duration of the trial (except 
dpi 10), pigs in the T03-LAW group shed significantly 
lower numbers of L. intracellularis compared to VAC-
LAW and POS-CONTROL pigs. The AUC was highest 
and not different for T01-LAW, VAC-LAW, and POS-
CONTROL while it was significantly (P < 0.05) reduced 
for T02-LAW and T03-LAW (Table 3).  
Macroscopic lesions
Macroscopic lesions were not observed in the NEG-
CONTROL group while lesions consistent with L. 
intracellularis infection including hemorrhagic pro-
liferative enteritis with inflammation, petechial hem-
orrhages, ulcers and thickening of the distal small 
intestine mucosa were observed in the other groups. 
Specifically, the mean group macroscopic ileum 
thickening based on subjective individual scores was 
0.8 ± 0.3 for T01-LAW, 1.0 ± 0.1 for T02-LAW, 0.9 ± 0.1 
for T03-LAW, 1.3 ± 0.3 for VAC-LAW and 1.9 ± 0.2 for 
POS-CONTROL pigs. The thickening was significantly 
reduced (P < 0.05) in the T01-LAW, T02-LAW and T03-
LAW group compared to the POS-CONTROL pigs. 
Often the intestinal content was fluid and bloody with 
necrotic debris adhered to the mucosa. Liquid intes-
tinal content (score 3) was present in 1/10 T01-LAW 
pigs, 0/10 T02-LAW pigs, 0/10 T03-LAW pigs, 1/10 
VAC-LAW pigs and 8/20 POS-CONTROL pigs. In 
addition, mesenteric lymph nodes were often macro-
scopically enlarged.
Table 2 Average daily weight gain (ADG) in grams ± SEM 
before or after L. intracellularis infection 
a Different superscripts (A,B) indicate a significant different ADG (P < 0.05) 
among groups during a time period.
Group Before inoculation
2.5–7 weeks of age
After inoculation
7–9 weeks of age
T01‑LAW 435.2 ± 21.3A,a 712.7 ± 32.2A
T02‑LAW 408.0 ± 30.0A 665.3 ± 32.9A
T03‑LAW 473.5 ± 12.3A 646.3 ± 21.1A
VAC‑LAW 413.2 ± 18.4A 623.3 ± 34.0A
NEG‑CONTROL 424.3 ± 19.8A 877.8 ± 32.8B
POS‑CONTROL 451.5 ± 9.8A 627.2 ± 27.2A
Figure 3 Group mean log10 L. intracellularis DNA in rectal swabs over time. Different superscripts (A,B,C) at a day post‑challenge indicate a 
significant (P < 0.05) difference among groups.
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Figure 4 Heat map outlining L. intracelluaris fecal shedding and tissue levels for each pig. Fecal shedding was determined by L. intracelluaris 
PCR on rectal swabs and tissue levels were assessed at necropsy (D16) by immunohistochemistry on formalin‑fixed ileum sections.
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Microscopic lesions
Histological analysis of the intestinal tissue revealed 
lesions typical of L. intracellularis including crypt 
epithelial hyperplasia, increased numbers of mitotic 
figures throughout the crypt, depletion of goblet cells 
and presence of L. intracellularis antigen in entero-
cytes. The mean microscopic lesions are summarized 
in Table  4. Severe L. intracellularis associated lesions 
were identified in 30% of the T01-LAW pigs, 10% of the 
T02-LAW pigs, 40% of the VAC-LAW pigs and 55% of 
the POS-CONTROL pigs while severe lesions were not 
present in NEG-CONTROL or T03-LAW pigs. L. intra-
cellularis antigen was identified in 9/10 T01-LAW pigs 
(0.7 ± 0.3), 9/10 T02-LAW pigs (0.3 ± 0.2), 9/10 T03-
LAW pigs (0.2 ± 0.1), 8/10 VAC-LAW pigs (0.7 ± 0.2), 
0/10 NEG-CONTROL pigs, and 18/20 POS-CON-
TROL pigs (1.2 ± 0.2). The L. intracellularis antigen 
levels were significantly (P < 0.05) higher in T01-LAW, 
VAC-LAW and POS-CONTROL pigs compared to 
NEG-CONTROL pigs, whereas there were significantly 
(P < 0.05) lower antigen amounts in T02-LAW and T03-
LAW compared to POS-CONTROL pigs (Figure 4).
PAS and IAP staining and correlation with disease
PAS staining reveals the presence of mucopolysaccha-
rides, glycoproteins, and/or glycogen and is tradition-
ally used for the assessment of goblet cells, which are 
depleted during L. intracellularis infection [24]. The 
group mean PAS staining intensity was 2.2 ± 0.1 for 
NEG-CONTROLs, 1.3 ± 0.1 for T01-LAW, 1.4 ± 0.1 for 
T02-LAW, 1.5 ± 0.1 for T03-LAW, 1.4 ± 0.1 for VAC-
LAW and 1.3 ± 0.1 for POS-CONTROL pigs. IAP, a 
brush-border enzyme, is an indicator of gut mucosal 
integrity and marker for crypt-villus differentiation [26]. 
The group mean IAP staining intensity was 5.5 ± 0.5 for 
NEG-CONTROL pigs, 1.2 ± 0.3 for T01-LAW, 1.7 ± 0.6 
for T02-LAW, 2.6 ± 0.7 for T03-LAW, 2.3 ± 0.6 for 
VAC-LAW and 1.7 ± 0.5 for POS-CONTROL pigs. All 
groups infected with L. intracellularis had a significantly 
(P < 0.001) lower mean staining intensity compared to 
NEG-CONTROL pigs for both PAS and IAP.
PAS stain had an AUC of 0.9 ± 0.0. At a cutoff value of 
1.6 the sensitivity was 100% and the specificity was 75%. 
Using this cutoff all NEG-CONTROL pigs were consid-
ered healthy while only 25% (15/60) of the L. intracellu-
laris infected pigs were considered healthy. For the IAP 
stain, the AUC was 0.9 ± 0.0. At a cutoff value of 3.6 the 
sensitivity was 100% and the specificity was 83% and all 
NEG-CONTROL pigs were considered healthy, while 
16.7% (10/60) of the L. intracellularis infected pigs were 
considered healthy. The correlation of PAS stain intensity 
with an ileum lesion severity score (a combined histopa-
thology and immunohistochemistry score) was moderate 
(−0.536) and it was high (−0.752) for L. intracellula-
ris shedding length. The correlation of IAP stain inten-
sity with the ileum severity score was low (−0.467) and 
it was moderate with L. intracellularis shedding length 
(−0.672).
Discussion
In this study, T02-LAW and T03-LAW groups showed 
a delayed L. intracellularis shedding compared to the 
POS-CONTROL group. The T02-LAW group was sig-
nificantly different from the POS-CONTROL and the 
Table 3 L. intracellularis shedding characteristics 
Log group mean L. intracellularis genomic copies ± SEM in fecal swabs at different days post-infection (dpi), area under the curve (AUC) and shedding length in weeks.
a Different superscripts (A,B,C,D) indicate a significant different weight gain (P < 0.05) among groups during a time period.
Group 2 4 6 8 10 12 15 AUC Shedding length
T01‑LAW 0 (0) 0.1 ± 0.1A,B,a 0.9 ± 0.3A,B 2.0 ± 0.4A,B 2.8 ± 0.4A 3.4 ± 0.4A,B 4.8 ± 0.3A 11.6A,B 3.6 ± 0.3A,B
T02‑LAW 0 (0) 0 (0)A 0.3 ± 0.2A 0.9 ± 0.4A,C 2.2 ± 0.3A 3.1 ± 0.3A,B 4.0 ± 0.3A,B 8.5B,C 2.6 ± 0.3B,C
T03‑LAW 0 (0) 0 (0)A 0 (0)A 0.3 ± 0.2C 2.1 ± 0.3A 2.5 ± 0.3A 3.1 ± 0.3B 6.4C 2.0 ± 0.3C
VAC‑LAW 0 (0) 0.8 ± 0.2B 2.0 ± 0.4B 2.7 ± 0.4B 2.7 ± 0.4A 4.1 ± 0.3B 4.3 ± 0.3A 14.5A 4.4 ± 0.3A
NEG‑CONTROL 0 (0) 0A 0A 0C 0B 0C 0C 0D 0D
POS‑CONTROL 5 (0.1 ± 0.1) 0.6 ± 0.2B 1.7 ± 0.3B 2.6 ± 0.3B 2.9 ± 0.3A 3.8 ± 0.3B 3.8 ± 0.2A 14.1A 4.1 ± 0.2A
Table 4 Group mean microscopic L. intracellularis lesion 
score 
The score is based on a combination of intestinal hyperplasia, inflammation and 
L. intracellularis antigen and distribution of the pigs in each group into normal 
(score 0), mild (score 1, 2 or 3), moderate (score 4, 5 or 6) or severe (score 7, 8 or 
9).
a Different superscripts (A,B) indicate a significant different weight gain 
(P < 0.05) among groups during a time period.
Group Mean lesion 
score (range: 
0–9)
Lesion severity distribution
Normal Mild Moderate Severe
T01‑LAW 4.3 ± 0.9A 1 3 3 3
T02‑LAW 3.3 ± 0.7A 1 8 0 1
T03‑LAW 3.3 ± 0.5A 1 6 3 0
VAC‑LAW 4.9 ± 1.1A 1 4 1 4
NEG‑CONTROL 0.0 ± 0.0B 10 0 0 0
POS‑CONTROL 5.6 ± 0.8A 2 5 2 11
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VAC-LAW group on dpi 6 and dpi 8. The T03-LAW 
group had significantly lower fecal shedding of L. intra-
cellularis throughout the study period (except on dpi 10). 
In addition, microscopic lesions consistent with severe 
L. intracellularis infection (scores of 7, 8 and 9) were not 
seen in the T03-LAW pigs. Interestingly, pigs in groups 
T02-LAW and T03-LAW had a delayed or limited sero-
conversion against L. intracellularis, with only 10% of 
the pigs in the T03-LAW group seroconverting by dpi 
15. This could reflect the delay in the colonization of the 
intestinal tissue by L. intracellularis in the T02-LAW 
and T03-LAW groups and thereby delay in the onset of 
humoral immune response against the pathogen. This 
is further corroborated by the observation that no fecal 
shedding could be observed in the T03-LAW group on 
dpi 6. Furthermore, on dpi 8, only 2/10 of the T03-LAW 
pigs were shedding compared to 18/20 POS-CONTROL 
pigs, indicating the degree of mitigation. Probiotic organ-
isms B. amyloliquefaciens and B. licheniformis, fed to the 
groups T01-LAW and T02-LAW, respectively, were also 
effective in mitigating the shedding of the L. intracellu-
laris albeit to a lesser degree than the B. pumilus. While 
B. amyloliquefaciens and B. licheniformis may also offer 
a certain level of protection against enteric pathogens in 
pigs and other livestock species [27], their antibacterial 
activity needs to be better characterized.
Numerous modes by which the Bacillus spp. mediate 
their probiotic action have been described [28]. Secre-
tion of competence- and sporulation-stimulating factor 
by the Bacillus spp. has been shown to induce resistance 
to oxidative damage in host intestinal cells and improve 
their barrier function [29]. Bacillus spp. are also known 
to produce cyclic lipo-peptides which have a variety of 
activities including interactions with biofilms, and anti-
fungal, anti-inflammatory, anti-tumor, anti-virus proper-
ties [30]. Surfactins, Iturins, Fengycins, Pumilacidins are 
families of such lipopeptides produced by many Bacillus 
spp. The lipopeptides are known to self-assemble and 
form micelles which have surfactant activity on biological 
membranes [31]. Bacillus pumilus is known to lyse cells 
of Vibrio spp. [32]. Polyketides are another family of com-
pounds produced by the Bacillus spp. which have potent 
antibacterial activity, besides other biological activity 
[33]. The compounds produced by Bacillus spp. may have 
a direct effect on the L. intracellularis and may also pre-
vent the colonization of enterocytes by L. intracellularis 
by inhibition of the pathogens host cell adhesion or entry.
Probiotics may act synergistically when used in com-
bination, as their mode of action may be complementary 
to one another. Further, in spite of a challenge dose of 
3 × 107 L. intracellularis organisms and the intragastric 
inoculation route used in this study, the T03-LAW group 
had significantly lower fecal shedding of L. intracellularis 
at dpi 4, 6, 8, 12 and 15 compared to POS-CONTROL 
and VAC-LAW groups, and fewer and less severe, but not 
statistically different, gross and histopathological lesions 
than the VAC-LAW group. The L. intracellularis spe-
cific antibodies, especially IgA, induced by vaccines are 
thought to be important in mediating protection against 
infection of enterocytes by L. intracellularis and efforts 
to bolster the IgA in the ileal mucosa by feed supple-
mentation with short-chain fructo-oligosaccharide have 
shown improved protection against L. intracellularis 
[15, 34]. In this study, total Ig antibody levels in serum 
without differentiation between IgM, IgG or IgA were 
measured. It may be interesting to determine IgA levels 
on the obtained samples to investigate if a lack of IgA 
could have been responsible for the results observed in 
the VAC-LAW pigs under the conditions of this study. 
The observations here suggest that B. pumilus may be 
able to prevent or limit the infection of enterocytes by 
L. intracellularis due to a yet unknown mechanism. This 
warrants further investigation especially under field 
conditions with the natural dynamics of infection, i.e., a 
lower but constant dose of infectious exposure at play. 
Identifying the mechanism by which B. pumilus inhibits 
L. intracellularis, a major primary pathogen in pig pro-
duction around the world and also a risk factor for other 
enteric pathogens such as Salmonella enterica serovar 
Typhimurium [35, 36], would be a novel effort and sup-
port the cause of reducing antibiotics usage in food ani-
mal production.
The results of this study indicate that B. pumilus effi-
ciently prevented early colonization of L. intracellularis 
in the pig enteric system as evidenced by reduced fecal 
shedding with a significantly lower AUC, even in the face 
of a high-dose experimental inoculation. The two other 
probiotics, B. amyloliquefaciens and B. licheniformis, 
displayed any anti-L. intracellularis effect to a lesser 
extent. This study warrants further detailed exploration 
of the potential of the B. pumilus to prevent or limit the 
impact of L. intracellularis infection in growing pigs.
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